當前商標狀態均為等待實質審查 。華為技術有限公司申請注冊“鴻蒙星河”“HARMONYOS NEXT”商標 ,天眼查 |
光算谷歌seo公司光算谷歌seo公司光算谷歌seo代运营光算谷歌广告光算谷歌广告光算谷歌外鏈光算爬虫池光算谷歌seo代运营光算蜘蛛池光算谷歌seo公司光算谷歌推广https://synapse.patsnap.com/drug/e0eff52f8c8b4231a0d237cb90fcc245https://synapse.patsnap.com/drug/2b0630c7ec4546bab02406dee676e40bhttps://synapse.patsnap.com/drug/07bb88005dbd4684be1b7bb9e7cf2137https://synapse.patsnap.com/article/what-are-the-preclinical-assets-being-developed-for-vdrhttps://synapse.patsnap.com/article/what-is-fostamatinib-disodium-used-forhttps://synapse.patsnap.com/drug/9d2c9890380d436983388ac7b8e1d354https://synapse.patsnap.com/article/what-are-the-side-effects-of-glisentidehttps://synapse.patsnap.com/article/what-is-the-mechanism-of-vorapaxar-sulfatehttps://synapse.patsnap.com/article/arcturus-therapeutics-reports-progress-in-cystic-fibrosis-programhttps://synapse.patsnap.com/drug/3375e71b0b1f4ba6b2ad542707d50430https://synapse.patsnap.com/blog/sandozs-tyruko-natalizumab-a-unique-biosimilar-for-multiple-sclerosishttps://synapse.patsnap.com/article/what-is-the-mechanism-of-chlorambucilhttps://synapse.patsnap.com/drug/606eeed9b19033b9b9955a94530433d1https://synapse.patsnap.com/drug/0c06cac350a04bf2afd55e821eec41c6https://synapse.patsnap.com/article/taiho-an-otsuka-unit-acquires-swiss-startup-araris-with-three-adcs-close-to-clinical-trialshttps://synapse.patsnap.com/drug/533f30dd3e0e49deb84813eca1fc1db8https://synapse.patsnap.com/article/fda-approves-roche%25E2%2580%2599s-vabysmo-syringe-for-major-vision-loss-causeshttps://synapse.patsnap.com/drug/72e8022adeac42a89a83e4178d86bd91https://synapse.patsnap.com/article/what-are-the-different-types-of-drugs-available-for-small-molecule-drug-conjugateshttps://synapse.patsnap.com/drug/8f886cd60fb54d62a6c2982188e1e043https://synapse.patsnap.com/drug/8be577aa033e1f37c346eaac0266bb1fhttps://synapse.patsnap.com/article/what-is-erythromycin-lactobionate-used-forhttps://synapse.patsnap.com/article/what-is-pegulicianine-used-forhttps://synapse.patsnap.com/article/quince-therapeutics-announces-lancet-neurology-publication-of-phase-3-erydex-trial-data-for-a-t-treatmenthttps://synapse.patsnap.com/article/what-is-the-mechanism-of-acyclovirhttps://synapse.patsnap.com/article/what-are-pdpn-inhibitors-and-how-do-they-workhttps://synapse.patsnap.com/drug/01b901c866f3479584068e1feff82490https://synapse.patsnap.com/drug/bcf115e1eaf34bab8cd96506d683af00https://synapse.patsnap.com/drug/84e4331ee882486183706883ee329b80https://synapse.patsnap.com/article/abivax-updates-uc-therapy-strategy-announces-early-preclinical-data-on-obefazimod-and-etrasimod-in-ibd-mouse-model